Predictive Oncology’s Post

🔬 Join Crown Bioscience for an upcoming webinar to explore how Antibody-drug conjugates (ADCs) are revolutionizing cancer treatment with improved targeting, reduced toxicity, and enhanced efficacy. 💡 Learn about cutting-edge advancements in bioconjugation technology and multi-omics approaches driving ADCs from preclinical to clinical stages. 🔍 Dr. Peng Wang, PhD, will share strategies for optimizing ADCs, overcoming resistance, and combining them with immuno-oncology therapies. ➡️ REGISTER HERE: https://buff.ly/3A9LOzt #DrugDevelopment #PrecisionMedicine #DrugDiscovery #ClinicalResearch #Oncology #OncologyDrugs #TherapeuticAreas #AntibodyDrugConjugate #PreClinical #BasicResearch

🚀 New Episode Alert! 🚀 FluoSphera & Spirochrome: Episode 2 🎥 We are thrilled to share the next chapter in our series with Spirochrome! In this episode, we demonstrate the selective binding of trastuzumab within co-cultured cancer spheroids, combined with the precision of PKmem probes. Our real-time imaging over five hours beautifully captures the progressive binding of trastuzumab-FITC to targeted cancer cells. 🧪 This experiment represents a major milestone in leveraging multiplexed 3D cell culture systems for oncology research. It allows us to closely mimic and study the complexities of tumor microenvironments, pushing us closer to transforming drug discovery with greater precision and confidence. Spirochrome’s advanced probes demonstrate their exceptional compatibility with our systems, enabling unmatched observation and insights into cellular processes. Congratulations to our incredible team and partners for making this achievement a reality! 💡 Stay tuned for Episode 3! 🎬 #Oncology #3DCellCulture #DrugDiscovery #FluoSphera #Innovation #Biotech #Spirochrome #PKmem #ACCESSGeneva

💫In case you missed it - #SOHO2024 poster is now up! Last week, we presented at the Society of Hematologic Oncology 2024 annual meeting. Our scientist Jianli Zhou, Ph.D., shared some of the innovative work powered by Lantern Pharma Inc. (Nasdaq: LTRN)'s AI platform RADR® and were able to connect with the #CancerResearch community. Leveraging Artificial Intelligence, Machine Learning, and genomics, we are working towards transforming the cost, pace, and timeline of oncology drug discovery and development. In our poster presented at #SOHO, we highlighted updates on our drug candidate LP-284, currently in Phase 1 #clinicaltrial for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas and Solid Tumors. Check out the poster at our website: https://bit.ly/3yIRBLW #Oncology #OncologyResearch #2024SOHO

🔈 📣 interested to learn about strategies for optimizing ADCs, overcoming resistance, and combining them with immuno-oncology therapies? 👉 Check out this webinar below! #ADC #cancertreatment #crownbioscience 🔬

Gratitude Overflowing: Reflecting on ESMO TAT 2024 Participation and Presentation Heartfelt thanks to the organizers and attendees of ESMO TAT 2024 for an enriching experience immersed in the forefront of oncological innovation. Presenting my PhD work in this esteemed conference was a privilege, offering profound insights and invaluable connections in the dynamic landscape of cancer therapeutics. The conference served as a hub for collaboration, fostering connections and sparking discussions that promise to shape the future of anti-cancer development. Breakthroughs in novel kinase inhibitors, oral immunotherapies, and next-generation macromolecules underscored the relentless pursuit of therapeutic evolution. Insights from industry leaders and discussions on methodological and regulatory challenges added invaluable depth to the known. #ESMO #posterpresentation #internationalconference2024 #milestones #cancerresearch #science #PhDlife

Calling all #biopharma researchers! Looking for new cancer drug candidates? Need trusted genomic data to validate targets? Compiling data for clinical trial design?? Look no further! COSMIC and HSMD are here to supercharge your research efforts. These expert-curated somatic databases are your keys to unlocking fast, cost-effective, and precise cancer #drugdiscovery and development. Special offer: Click here to learn more, get a free trial, plus free sample data https://buff.ly/3Vqw6Z4 QIAGEN Digital Insights

CTC diagnostics involves the detection and analysis of cancer cells that have broken away from the primary tumor and are circulating in the bloodstream. These cells provide invaluable insights into the progression of cancer, enabling oncologists to monitor the disease in real-time, tailor treatments to individual patients, and potentially improve outcomes.   Top Global Circulating Tumor Cell Diagnostics Industry Players: QIAGEN Bio-Techne Precision For Medicine BioCep Greiner Bio-One International Ikonisys Miltenyi Biotec BioFluidica, Inc. Biolidics Limited (Formerly known as Clearbridge BioMedics) Epic Sciences Rarecells ScreenCell Menarini Silicon Biosystems Vitatex Inc   Read More @ https://lnkd.in/dz9zMhuj   #ctcdiagnostics #liquidbiopsy #precisionmedicine #cancerdiagnostics #oncology #biotechnology #medtech #ctc #marketgrowth#liquidbiopsy #personalizedmedicinerevolution #healthcare #investinginhealthcare #ctcdrugdevelopment #earlycancerdetection #residualdisease #cancertreatment #startup #metastatinsight

DELFI Diagnostics published promising data in the journal Cancer Discovery, outlining the performance and potential of its blood-based #AI test to screen for #lungcancer. https://lnkd.in/de2aS-gv #artificialintelligence #biotechnology #clinicalresearch #DELFIDiagnostics #diagnostics #imaging #IVDs #medicalaffairs #oncology

🔬 Join Wren Laboratories for an upcoming webinar to explore the transformative potential of #liquidbiopsy and multigene mRNA expression assays in clinical trials. The featured speakers will showcase the clinical validity of NETest® and PROSTest® assays for neuroendocrine tumors and prostate cancer, while also discussing their use in biomarker discovery, proof-of-concept (POC), and pharmacodynamics (PD) studies. 🔍 Learn more + register here: https://buff.ly/3XiuxvK #Biopsy #PrecisionMedicine #ClinicalResearch #Oncology #Biomarkers #CDx #Diagnostics #TherapeuticAreas #LaboratoryTechnology #LiquidBiopsyCancer

🔬 Join Wren Laboratories for an upcoming webinar to explore the transformative potential of #liquidbiopsy and multigene mRNA expression assays in clinical trials. Abdel Halim, PharmD, MSc, PhD, DABCC will showcase the clinical validity of NETest® and PROSTest® assays for neuroendocrine tumors and prostate cancer, while also discussing their use in biomarker discovery, proof-of-concept (POC), and pharmacodynamics (PD) studies. 🔍 Learn more + register here: https://buff.ly/3XiuxvK #Biopsy #PrecisionMedicine #ClinicalResearch #Oncology #Biomarkers #CDx #Diagnostics #TherapeuticAreas #LaboratoryTechnology #LiquidBiopsyCancer